The Alzheimer's Disease Risk Genes MS4A4A and MS4A6A Cooperate to Negatively Regulate TREM2 and Microglia States
SSRN Electronic Journal2025
Dalya R. Soond, Jessica D. Sun, Angie Yee, Chaitanya Wagh, Anna Rychkova, Rita Cacace, Daniel R. Gulbranson, Xiaoting Wang, Alice Buonfiglioli, Muhammad Alhawagri, Pei Ann Kong, Marina K. Roell, Wei‐Hsien Ho, Belvin Gong, Heidi Denton, Giacomo Muscanera, Tim Meese, Mohamed El‐Khatib, Daniel P. Bermingham, Adiljan Ibrahim, Julia Kuhn, Hervé Rhinn, Zia Khan, Ananya Mitra, Tina Schwabe, Karpagam Srinivisan, Ilaria Tassi, Lot D. de Witte, Renzo Mancuso, Hua Long, Peter Heutink, Sara Kenkare-Mitra, Arnon Rosenthal
Related Papers
- → TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease(2023)107 cited
- → Naturally-aged microglia exhibit phagocytic dysfunction accompanied by gene expression changes reflective of underlying neurologic disease(2022)84 cited
- → TREM2, microglial and ischemic stroke(2023)28 cited
- → TREM2-dependent senescent microglia conserved in aging and Alzheimer’s disease(2023)5 cited
- → Naturally-aged microglia exhibit phagocytic dysfunction accompanied by gene expression changes reflective of underlying neurologic disease(2022)3 cited